Evidence map›Paper›PMID 32803563›Full record

ReviewInternational urology and nephrology2021

Dialysis prescription in acute kidney injury: when and how much?

Juan C Badel, Lautaro A Garcia, Manuel J Soto-Doria, Carlos G Musso

Abstract readReview
PubMed Publisher
In one paragraph

Review in International urology and nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juan C BadelPhysiology Department, Instituto Universitario del Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Lautaro A GarciaPhysiology Department, Instituto Universitario del Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Manuel J Soto-DoriaClínica IMAT Oncomédica, Montería, Colombia.
Carlos G MussoPhysiology Department, Instituto Universitario del Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. carlos.musso@hospitalitaliano.org.ar.ORCID http://orcid.org/0000-0001-8666-1130

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) constitutes a serious public health problem because of its very high cost and mortality rate, with an increasing incidence, phenomenon which is explained by the increasingly number of older patients suffering from several comorbidities admitted in the intensive care units. Despite the new AKI definition and classification, the use of novel AKI biomarkers and modern technologies, as an attempt to achieve an early AKI detection and treatment, and consequently to better clinical outcomes, AKI mortality particularly in ICU patients remains persistently high. In the present article, the currently accepted concepts regarding dose and time of hemodialysis and peritoneal dialysis prescription in AKI patients have been reviewed.

Indexed as

Renal DialysisAcute Kidney InjuryHumansPeritoneal DialysisTime FactorsAcute kidney injuryDialysisDosePrescription

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.